XYLO logo

Xylo Technologies (XYLO)

Profile

Full Name

Xylo Technologies

Ticker Symbol

XYLO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

Israel

IPO

Indexes

Not included

Website

http://www.medigus.com

Employees

84

Key Details

Price

$4.95(-4.81%)

Market cap

Last Dividend

$2.27

TTM Dividend yield

-

Annual revenue

$91.72M(-0.15% YoY)

Annual EPS

-$25.20(-57.50% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.95
XYLO price is $4.95

30-Day Relative Volume

0.13
XYLO 30-day relative volume is 0.13

Price Performance

Price Most recent change

-4.81%
XYLO price was down -4.81% on Apr 17, 2025

Price YTD change

+36.74%
XYLO price is up +36.74% since January 1st

Price 1-year change

-21.34%
XYLO price is down -21.34% year-on-year

Price 3-year change

-87.75%
XYLO price is down -87.75% over the past 3 years

Price Range

Price All-time high

$8272.00
XYLO price is currently -99.94% below its historical high of $8272.00

Price 3-year low

$2.70
XYLO price is currently +83.33% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.62M
XYLO market capitalization is $3.62 million

Market cap 3-year change

-84.96%
XYLO market capitalization is down -84.96% over the past 3 years

Market cap All-time high

$73.92M
XYLO market capitalization is currently -95.10% below its historical high of $73.92 million

Market cap sector rank

10.21%
XYLO market capitalization is higher than 10.21% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.04%
XYLO shares outstanding is up +3.04% year-on-year

Shares Outstanding 3-Year Change

+22.77%
XYLO shares outstanding is up +22.77% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.96
XYLO beta is 0.96

200-day SMA

$4.07
XYLO price is currently +21.54% above its 200-day simple moving average

50-day SMA

$4.79
XYLO price is currently +3.45% above its 50-day simple moving average

RSI

49.69
XYLO 14-day relative strength index is 49.69

Volume

0.13
XYLO 30-day relative volume is 0.13

ATR

$0.59
XYLO average true range is $0.59

10-day Historical Volatility

104.50%
XYLO 10-day historical volatility is 104.50%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$2.27
XYLO last dividend was $2.27 per share, with an ex-dividend date of December 19, 2022

Next Dividend

-
XYLO next dividend has not yet been announced

Dividend per share

Dividend per share

-
XYLO annual dividend per share value is unknown

Dividend per share Sector Rank

-
XYLO annual dividend per share is unknown

Dividend per share 1-Year Change

-
XYLO annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
XYLO annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
XYLO annual dividend yield value is unknown

Dividend yield Sector Rank

-
XYLO annual dividend yield is unknown

Other

Payout ratio

0.00%
XYLO annual payout ratio is 0.00%

Dividends paid

$0.00
XYLO annual dividends paid is $0.00

Free cash flow

-$7.99M
XYLO annual free cash flow is -$7.99 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$91.72M
XYLO annual revenue is $91.72 million

Revenue Analysts estimate

$105.00M
XYLO annual revenue is currently -12.64% lower than the consensus analysts' forecast

Revenue 1-year change

-0.15%
XYLO annual revenue is down -0.15% year-on-year

Revenue Sector rank

55.38%
XYLO annual revenue is higher than 55.38% of companies in Healthcare sector

EPS

EPS

-$25.20
XYLO annual earnings per share is -$25.20

EPS Analysts estimate

$0.48
XYLO annual earnings per share is currently -5350.00% lower than the consensus analysts' forecast

EPS 1-year change

-57.5%
XYLO annual earnings per share is down -57.5% year-on-year

EPS Sector rank

5.8%
XYLO annual earnings per share is higher than 5.8% of companies in Healthcare sector

Profit

Gross profit

$11.84M
XYLO annual gross profit is $11.84 million

Gross margin

12.91%
XYLO annual gross profit margin is 12.91%

Operating profit

-$10.81M
XYLO annual operating income is -$10.81 million

Operating margin

-11.79%
XYLO annual operating profit margin is -11.79%

Net income

-$16.02M
XYLO annual net profit is -$16.02 million

Net margin

-17.47%
XYLO annual net profit margin is -17.47%

Expenses

Total expenses

$102.54M
XYLO annual total expenses is $102.54 million

Operating expenses

$22.66M
XYLO annual total operating expenses is $22.66 million

Cost of goods sold

$79.88M
XYLO annual cost of goods sold is $79.88 million

Selling, general & administrative expenses

$16.77M
XYLO annual SGA is $16.77 million

Depreciation and amortization

$3.98M
XYLO annual depreciation & amortization is $3.98 million

Interest expense

$1.53M
XYLO annual interest expense is $1.53 million

Income tax

-$74.00K
XYLO annual income tax is -$74.00 thousand

EBIT & EBITDA

EBIT

-$20.27M
XYLO annual earnings before interest & taxes is -$20.27 million

EBITDA

-$16.30M
XYLO annual EBITDA is -$16.30 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$63.90M
XYLO annual total assets is $63.90 million

Non current assets

$32.23M
XYLO annual long term assets is $32.23 million

Current assets

$31.67M
XYLO annual total current assets is $31.67 million

Cash and cash equivalents

$9.36M
XYLO annual cash & cash equivalents is $9.36 million

Accounts receivable

$12.32M
XYLO annual accounts receivable is $12.32 million

Inventory

$2.39M
XYLO annual inventory is $2.39 million

Liabilities

Total liabilities

$31.46M
XYLO annual total liabilities is $31.46 million

Long term liabilities

$2.19M
XYLO annual total long term liabilities is $2.19 million

Current liabilities

$29.27M
XYLO annual total current liabilities is $29.27 million

Accounts payable

$13.25M
XYLO annual accounts payable is $13.25 million

Debt

Total debt

$9.79M
XYLO annual total debt is $9.79 million

Total debt 1-year change

-3.44%
XYLO annual total debt is down -3.44% year-on-year

Long term debt

$702.00K
XYLO annual long term debt is $702.00 thousand

Short term debt

$9.08M
XYLO annual short term debt is $9.08 million

Equity & Capital

Shareholders equity

$23.58M
XYLO annual stockholders equity is $23.58 million

Book value

$23.58M
XYLO annual book value is $23.58 million

Retained earnings

-$101.61M
XYLO annual retained earnings is -$101.61 million

Working capital

$2.40M
XYLO annual working capital is $2.40 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.25M
XYLO annual cash flow from operations is -$6.25 million

Cash from operations 1-year change

-10.45%
XYLO annual cash flow from operations is down -10.45% year-on-year

Cash from investing

-$1.44M
XYLO annual cash flow from investing activities is -$1.44 million

Cash from investing 1-year change

+67.87%
XYLO annual cash flow from investing activities is up +67.87% year-on-year

Cash from financing

-$3.15M
XYLO annual cash flow from financing activities is -$3.15 million

Cash from financing 1-year change

-158.21%
XYLO annual cash flow from financing activities is down -158.21% year-on-year

CAPEX

CAPEX

$1.75M
XYLO annual capital expenditures is $1.75 million

CAPEX 1-year change

+2260.81%
XYLO annual capital expenditures is up +2260.81% year-on-year

Free Cash Flow

Free cash flow

-$7.99M
XYLO annual free cash flow is -$7.99 million

Free cash flow 1-year change

-39.51%
XYLO annual free cash flow is down -39.51% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

12.91%
XYLO annual gross profit margin is 12.91%

Operating margin

-11.79%
XYLO annual operating profit margin is -11.79%

Net margin

-17.47%
XYLO annual net profit margin is -17.47%

ROA & ROE

ROA

-19.84%
XYLO annual return on assets is -19.84%

ROE

-36.79%
XYLO annual return on equity is -36.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
XYLO price to earnings ratio value is unknown

PE ratio Sector rank

-
XYLO price to earnings ratio is unknown

PB Ratio

PB ratio

0.24
XYLO price to book ratio is 0.24

PB ratio Sector rank

21.19%
XYLO price to book ratio is higher than 21.19% of companies in Healthcare sector

PS Ratio

PS ratio

-
XYLO price to sales ratio value is unknown

PS ratio Sector rank

-
XYLO price to sales ratio is unknown

Enterprise value

Enterprise value

$3.44M
XYLO enterprise value is $3.44 million

Enterprise value Sector rank

17.11%
XYLO enterprise value is higher than 17.11% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
XYLO EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
XYLO EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.08
XYLO annual current ratio is 1.08

Quick ratio

1.00
XYLO annual quick ratio is 1.00

Leverage

Debt to equity

0.39
XYLO annual debt to equity ratio is 0.39

Interest coverage ratio

-13.23
XYLO annual interest coverage ratio is -13.23

Risk & Stability

Piotroski F-Score

-
XYLO piotroski f-score value is unknown

Altman Z-Score

-1.72
XYLO altman z-score is -1.72

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

JAGX logo
Jaguar Health (JAGX)
XRTX logo
XORTX Therapeutics (XRTX)
MBIO logo
Mustang Bio (MBIO)
HSCS logo
Heart Test Laboratories (HSCS)
GENE logo
Genetic Technologies Limited (GENE)
SNOA logo
Sonoma Pharmaceuticals (SNOA)
KTTA logo
Pasithea Therapeutics (KTTA)
ATIP logo
ATI Physical Therapy (ATIP)
XBIO logo
Xenetic Biosciences (XBIO)
  • What is the ticker symbol for Xylo Technologies?
  • Does Xylo Technologies pay dividends?
  • What sector is Xylo Technologies in?
  • What industry is Xylo Technologies in?
  • What country is Xylo Technologies based in?
  • Is Xylo Technologies in the S&P 500?
  • Is Xylo Technologies in the NASDAQ 100?
  • Is Xylo Technologies in the Dow Jones?
  • When was Xylo Technologies's last earnings report?
  • When does Xylo Technologies report earnings?

What is the ticker symbol for Xylo Technologies?

The ticker symbol for Xylo Technologies is NASDAQ:XYLO

Does Xylo Technologies pay dividends?

No, Xylo Technologies does not pay dividends

What sector is Xylo Technologies in?

Xylo Technologies is in the Healthcare sector

What industry is Xylo Technologies in?

Xylo Technologies is in the Medical Devices industry

What country is Xylo Technologies based in?

Xylo Technologies is headquartered in Israel

Is Xylo Technologies in the S&P 500?

No, Xylo Technologies is not included in the S&P 500 index

Is Xylo Technologies in the NASDAQ 100?

No, Xylo Technologies is not included in the NASDAQ 100 index

Is Xylo Technologies in the Dow Jones?

No, Xylo Technologies is not included in the Dow Jones index

When was Xylo Technologies's last earnings report?

Xylo Technologies's most recent earnings report was on Sep 20, 2021

When does Xylo Technologies report earnings?

The next expected earnings date for Xylo Technologies is May 15, 2025
On this page